Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 2, Number 3—July 1996
Synopsis

Antibody-Based Therapies for Emerging Infectious Diseases

Arturo CasadevallComments to Author 
Author affiliation: Albert Einstein College of Medicine, Bronx, New York, USA

Main Article

Figure 2

Schematic illustration of the major events in the development of serum therapy for pneumococcal pneumonia and meningococcal meningitis. For pneumococcal pneumonia, considerable uncertainty existed regarding the usefulness of serum therapy in the decades following the demonstration that immune sera could transfer protection to animals. However, the discovery that type-specific serum necessary for efficacy, followed by extensive clinical trials, led to the general acceptance of serum therapy for p

Figure 2. Schematic illustration of the major events in the development of serum therapy for pneumococcal pneumonia and meningococcal meningitis. For pneumococcal pneumonia, considerable uncertainty existed regarding the usefulness of serum therapy in the decades following the demonstration that immune sera could transfer protection to animals. However, the discovery that type-specific serum necessary for efficacy, followed by extensive clinical trials, led to the general acceptance of serum therapy for pneumococcal pneumonia in the late 1920s. For meningococcal meningitis, the antisera generated against the strains pervalent in the early 1900s proved to be effective in therapy. However, the efficacy of serum therapy in later epidemics of meningococcal meningitis was significantly lower, leading to uncertainty about the value of serum therapy for this infection (16).

Main Article

Page created: December 20, 2010
Page updated: December 20, 2010
Page reviewed: December 20, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external